Enzychem Lifesciences Corporation (KOSDAQ: 183490)

Enzychem Lifesciences Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	116,508	154,649	139,497	457,391	869,255	553,292
Market Cap Growth	6.04%	10.86%	-69.50%	-47.38%	57.11%	-27.13%
Enterprise Value	5,617	16,479	-29,937	400,389	835,243	517,193
Last Close Price	1456.00	1818.00	1655.00	9150.00	13885.04	9274.26
PE Ratio	-	-16.53	-5.23	-17.16	-38.67	-26.47
PS Ratio	1.45	2.03	5.24	19.91	33.67	17.58
PB Ratio	0.65	0.79	0.69	6.13	11.99	7.47
P/FCF Ratio	-18.09	-12.37	-6.26	-18.74	-51.57	-30.86
P/OCF Ratio	-21.71	-15.08	-9.74	-24.61	-62.00	-36.65
EV/Sales Ratio	0.07	0.22	-1.12	17.43	32.35	16.44
EV/EBITDA Ratio	-4.57	-1.47	2.44	-21.48	-48.93	-35.78
EV/EBIT Ratio	-3.39	-1.12	2.04	-19.29	-43.71	-31.53
EV/FCF Ratio	-0.61	-1.32	1.34	-16.40	-49.55	-28.85
Debt / Equity Ratio	0.02	0.03	0.19	0.70	0.59	0.04
Debt / FCF Ratio	-0.46	-0.45	-1.70	-2.13	-2.55	-0.17
Asset Turnover	0.41	0.33	0.14	0.18	0.25	0.41
Inventory Turnover	5.51	5.80	2.67	2.59	2.82	3.85
Quick Ratio	11.64	10.63	4.79	1.87	9.72	7.29
Current Ratio	14.43	12.33	5.21	2.05	10.73	8.43
Return on Equity (ROE)	-4.71%	-4.74%	-18.16%	-37.87%	-23.90%	-25.41%
Return on Assets (ROA)	-4.16%	-4.01%	-4.81%	-10.10%	-11.44%	-13.49%
Return on Capital (ROIC)	-4.37%	-4.19%	-5.01%	-10.71%	-12.40%	-14.66%
Earnings Yield	-7.28%	-6.03%	-17.99%	-6.09%	-2.01%	-3.05%
FCF Yield	-7.94%	-8.09%	-15.97%	-5.34%	-1.94%	-3.24%
Buyback Yield / Dilution	26.94%	-7.75%	-56.10%	-3.93%	-3.53%	-3.34%
Total Shareholder Return	26.94%	-7.75%	-56.10%	-3.93%	-3.53%	-3.34%

Source: S&P Capital IQ. Standard template. Financial Sources.